CD8A and neoplasm: L‐Arg@CaPL emulsions not only neutralizes the tumor acidity via the reaction of CaP NPs with protons but also facilitates the release of L‐Arg, thereby synergistically promoting the reinvigoration of exhausted CD8+ T cells and effectively reversing tumor immunosuppression to promote TACE therapy.